Kratom: The Opioid at the Gas Station

Most parents have never heard of kratom.

That is exactly what makes it dangerous.

While families are watching for the substances they recognize, the ones with obvious cultural visibility, clear warning labels, or familiar street names, a different drug has been quietly gaining ground. It is sold in smoke shops, convenience stores, gas stations, and online retailers across the country. It is often marketed as a natural supplement, an herbal energy product, or a wellness aid. It may come as powder, capsules, gummies, or small liquid shots. It often looks more like a commercial product than something families would immediately associate with addiction risk.

Kratom can pose real risks for young people in its own right, including dependence that is easy to underestimate. Unfamiliarity does not create the risk. But it makes the risk far easier to miss.

Kratom hides in plain sight.

For families who have never heard of it, kratom does not fit the older mental picture of what dangerous drug exposure looks like. It looks ordinary. It looks commercial. It looks like something that belongs on a convenience store shelf, not something capable of creating real dependence or producing opioid-like effects.

What Kratom Actually Is

Kratom comes from Mitragyna speciosa, a tree native to Southeast Asia. Its best-known active compounds, mitragynine and 7-hydroxymitragynine, act at mu-opioid receptors in the brain.

At lower doses, kratom may produce more stimulant-like effects, such as increased energy or alertness. At higher doses, opioid-like effects become more prominent, including sedation, pain relief, and euphoria. That combination makes kratom especially confusing. A young person may begin using it because it seems energizing, manageable, or natural, without recognizing how quickly the pattern can shift toward dependence.

This is one reason kratom does not fit the mental model many families rely on. It does not look like heroin. It does not look like prescription pain medication. It may not even look like a drug.

But its pharmacology matters more than its packaging.

Why Awareness Is So Low

Research on adolescent use suggests kratom use is not widespread compared with cannabis or alcohol, but it is real, relevant, and often linked with broader substance involvement rather than appearing in isolation.

That matters because awareness has not kept pace with access.

Many families have never been told to look for kratom. Many schools are not talking about it. Many clinicians do not ask about it specifically. And young people may not volunteer it because they do not believe they are using something dangerous. They bought it at a gas station. It was marketed as legal. It was packaged like a supplement. As far as they know, it does not belong in the same category as other drugs.

That misunderstanding allows kratom to stay hidden longer than it should.

The Detection Problem

Another reason kratom can be missed is that routine drug screens typically do not test for kratom alkaloids unless a specific assay is ordered. A young person may be using kratom regularly without it appearing on a standard panel, and unless a clinician asks about kratom directly, the possibility may never even enter the assessment.

That changes the picture.

A teenager can be using a psychoactive, dependence-producing substance while still appearing to families, and even some providers, as if nothing identifiable is happening. Anxiety, gastrointestinal symptoms, sedation, agitation, or withdrawal-like symptoms may show up before the underlying substance is recognized.

Kratom is not invisible because it is harmless or because it barely exists. It is invisible because people are often not looking for it.

Dependence Can Develop Faster Than Families Realize

The literature and case reports are clear that regular kratom use can lead to dependence, and withdrawal can be significant. Reported symptoms include anxiety, irritability, restlessness, depressed mood, insomnia, muscle and body aches, tremor, diarrhea, and strong cravings. For a young person who began using kratom because it seemed harmless or natural, withdrawal can be frightening and physically destabilizing.

This is where the gap between marketing and reality becomes dangerous.

A product that looks benign can still create a pattern of physical dependence. A young person may not understand what is happening until stopping feels much harder than expected.

Families may miss it too. What they see may look like mood instability, physical illness, anxiety, or a young person who suddenly seems unable to function without some unidentified product. Unless kratom is named directly, it can be misread for a long time.

Treatment Is Not as Straightforward as Many Assume

Published case reports describe buprenorphine-based treatment as one approach that has been used to manage kratom withdrawal or kratom use disorder. This is the same class of medication widely used in the treatment of opioid use disorder, including both withdrawal management and maintenance treatment. But that does not mean there is a settled, standardized treatment pathway for kratom. Formal guidance remains limited, and treatment may require thoughtful, individualized management rather than simple assumptions based on more familiar opioid withdrawal patterns.

That distinction matters.

This is not simply a matter of applying old frameworks to a new product. Kratom sits in a gray area that creates confusion for families, clinicians, and treatment systems alike. Some young people may present with opioid-like withdrawal. Others may present with mixed symptoms that are easy to misunderstand.

Recognition has to come first.

Why This Matters Right Now

The adolescent substance-use landscape keeps changing. Some of the greatest risks are no longer limited to substances families immediately recognize. They are appearing in products that look commercial, normalized, easy to buy, and easy to explain away.

Kratom occupies a particularly dangerous position because it disrupts the mental model many adults still rely on. It is not prescribed. It may not be illegal where a family lives. It may be sold beside products marketed for energy, focus, or relaxation. And yet its best-known compounds act on the same receptor system that underlies the opioid crisis.

The young people most at risk are not only those already recognized as struggling. They may be students trying to manage stress, young people experimenting with something they found online or heard about from peers, or adolescents trying to self-medicate discomfort they do not yet know how to name.

That is what makes kratom especially important to understand. The entry point may look nothing like what families imagine addiction looks like.

What Families and Professionals Need to Do

For families, awareness matters. If a young person is showing unexplained anxiety, sedation, nausea, withdrawal-like symptoms, or secretive use involving powders, capsules, gummies, or small liquid bottles, kratom belongs on the list of possibilities.

For clinicians and other professionals working with young people, substance-use screening should include kratom by name. Not just opioids, cannabis, alcohol, and nicotine. Kratom specifically. A young person may not mention it otherwise, either because they do not think it counts or because they do not know what category it belongs in.

The danger of kratom is not only what it does pharmacologically.

It is also how easily it escapes notice.

That hidden quality is part of what makes kratom especially dangerous for young people, particularly when dependence can take hold faster than many families realize.